Skip to main content
OpenTrials

Clinical trial condition

Relapsing Remitting Multiple Sclerosis (RRMS)

Explore clinical trials studying Relapsing Remitting Multiple Sclerosis (RRMS). Study availability and eligibility vary by location and protocol.

11 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Relapsing Remitting Multiple Sclerosis (RRMS) trial results

Recruiting

ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS

NCT06733922

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Charcot-Marie-Tooth disease, Type 1F, +7 more
Locations
  • Novartis Investigative Site Calgary, Alberta, Canada
  • Novartis Investigative Site Calgary, Alberta, Canada
  • Novartis Investigative Site Edmonton, Alberta, Canada
  • Novartis Investigative Site Burnaby, British Columbia, Canada
View all 14 locations
View Trial Details
Completed

A Prospective, Open-label, Non-randomized, Clinical Trial to Determine if Natalizumab (Tysabri®) Improves Ambulatory Measures in Relapsing-remitting Multiple Sclerosis (RRMS) Patients

NCT00871780

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Biogen Idec Investigative Site Liège, Belgium
  • Biogen Idec Investigative Site Puebla City, Mexico
  • Biogen Idec Investigative Site Bialystok, Poland
  • Biogen Idec Investigative Site Bydgoszcz, Poland
View all 15 locations
View Trial Details
Completed

Observational Study to Analyse the Impact of Nurse Support and Disease Related Factors on Long- Term Adherence to Betaferon Treatment

NCT00787657

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Many Locations, Argentina
  • Many Locations, Bahrain
  • Many Locations, Belgium
  • Many Locations, Bosnia and Herzegovina
View all 36 locations
View Trial Details

Related conditions